Critically, our study extends this paradigm to pulmonary fibrosis: FSTL1 overexpression in A549 cells amplified NF-κB and cytokines (IL-1β/TNF-α/IL-6), FSTL1 inhibition attenuated TGF-β1-induced inflammation. The gene discussed is IL6; the disease is pulmonary fibrosis.